Status:

NOT_YET_RECRUITING

Outcome of Pulpotomy With MTA and Biodentin in Permanent Teeth With Caries Exposure

Lead Sponsor:

Altamash Institute of Dental Medicine

Conditions:

Pulpitis - Irreversible

Eligibility:

All Genders

18-40 years

Phase:

NA

Brief Summary

The success of pulpotomy treatment is affected by the type of biologically active material used.The effects of MTA and biodentine are compared in mature permanent teeth with caries exposure.It is expe...

Eligibility Criteria

Inclusion

  • mature permanent teeth

Exclusion

  • Teeth with restorations

Key Trial Info

Start Date :

May 2 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2025

Estimated Enrollment :

136 Patients enrolled

Trial Details

Trial ID

NCT06913283

Start Date

May 2 2025

End Date

July 1 2025

Last Update

April 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Altamash Institute of Dental Medicine

Karachi, Sindh, Pakistan, 75500

Outcome of Pulpotomy With MTA and Biodentin in Permanent Teeth With Caries Exposure | DecenTrialz